David H. Wang - 27 Oct 2025 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Signature
/s/ Mark McKechnie, Attorney-in-Fact for David H. Wang
Issuer symbol
ACMR
Transactions as of
27 Oct 2025
Net transactions value
$0
Form type
4
Filing time
29 Oct 2025, 21:30:12 UTC
Previous filing
30 Sep 2025
Next filing
05 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wang David H Chief Executive Officer, President and Director, Director, 10%+ Owner C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT /s/ Mark McKechnie, Attorney-in-Fact for David H. Wang 29 Oct 2025 0001721580

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACMR Class A Common Stock 100,002 27 Oct 2025 By Jing Chen, wife of David H. Wang
holding ACMR Class A Common Stock 45,837 27 Oct 2025 By Sophia Wang, daughter of David H. Wang
holding ACMR Class A Common Stock 180,000 27 Oct 2025 By David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children
holding ACMR Class A Common Stock 620,001 27 Oct 2025 By Wang-Chen Family Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Award $0 +545,400 $0.000000 545,400 27 Oct 2025 Class A Common Stock 545,400 $7.36 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 20, 2020, the reporting person was granted options to purchase an aggregate of 1,636,197 shares of the Issuer's Class A common stock, based on the satisfaction of certain performance criteria. In general, one-third of the shares subject to the options vest and become exercisable upon an increase in the Issuer's market capitalization (calculated as described in footnote 2) of $1 billion, $2 billion and $3 billion, respectively, from the market capitalization of $553,383,586 on the date of grant. 545,400 shares vested and became exercisable on October 27, 2025, which was the first trading day as of which the Issuer's market capitalization equaled or exceeded $2,553,383,586. The remaining shares will vest and become exercise upon the first trading days, if any, on which the Issuer's market capitalization equals or exceeds $3,553,383,586.
F2 For purposes of the options, the market capitalization as of a specified trading day is calculated by multiplying (a) the average of the daily volume-weighted average price per share of the Issuer's Class A common stock for each of the trading days occurring during the thirty calendar day period ending on that specified trading day by (b) the total number of issued and outstanding shares of the Issuer's Class A and Class B common stock as of 11:59 p.m. (Eastern time) on such specified trading day.

Remarks:

Chief Executive Officer, President and Director